Clinical studies showed that patients receiving chemotherapy have increased NFκB activity and cytokine expression, such as CXCL8, and a high level of CXCL8 compromises the docetaxel-mediated apoptosis of tumor cells14,15. Here, NFKB1 is linked to neoplasm.